Keywords
How to Cite
Abstract
Chronic heart failure (CHF) is an acute medical and social problem relating to the priorities of the national health systems of most countries of the world due to the increasing spread of this syndrome, despite the continuous improvement of treatment. The near future promises only the worsening of the problem: the incidence and prevalence of CHF increases due to the increase in life expectancy.
Thus, the need to clarify the features of the diagnosis of CHF in patients with diabetes mellitus and the improvement of their therapy is beyond doubt.
The aim of this research is to clarify the frequency of chronic heart failure in patients with diabetes type 2 in the specialized | department of the hospital and the unorganized urban population, to assess the adequacy of its diagnosis and treatment.
To achieve this goal, the following tasks:
1. To identify the prevalence of chronic heart failure in patients with diabetes type 2.
2. To assess the level of diagnosis of chronic heart failure in patients with diabetes type 2.
3. To analyze the state of drug therapy in patients with diabetes type 2 in the presence of chronic heart failure.
For the first time, the prevalence of CHF in patients with diabetes type 2 mellitus in an unorganized urban population studied.
References
Avdeev SN, Baymakanova GE. Strategy for managing a cardiological patient with COPD. Cardio is pulmonary relationship. Heart 2007; 6(6): 305-309.
Ageev FT, Ovchinnikov AG. Diastolic dysfunction as manifestations of cardiac remodeling. Heart Failure Journal 2002; 3: 190-195.
Ageev FT. Diastolic Heart Failure: 10 years dating. Journal of Heart Failure 2010; 11(1): 69-76.
Aleksandrov AA, Shatskaya OA, Kukharenko SS, Drozdova EH, Bondarenko IZ, Tabidze ND, Shestakova MV. Heart failure, diabetes, beta is blockers and the risk of hypoglycemia. RFK Journal 2008; 3(4): 47-51. https://doi.org/10.20996/1819-6446-2008-4-3-47-51
Alexandrov AA. Heart damage in endocrine diseases. The appendix on the CD to the national manual Cardiology. ed. Yu.N. Belenkova, R.G.Oganova. M.: GEOTAR is Media, 2007; pp. 12-32.
Aleksandrov AA. Diabetic heart: fight for mitochondria. Cons Ilium Medium 2003; 5(9): 50,95,13.
Aleksandrov AA. Metformin and cardiovascular complications of diabetes: "reflections at the main entrance." BCM-2008. T.16, ?11. p. 1544-1548.
Yu. Aronov DM. Treatment and prevention of atherosclerosis. M.; Triad-X, 2000; p. 411.
Aronov DM, Lupanov VP. Functional tests in cardiology. M.: MED press Inform 2007; p. 326.
Arutyunov GP. Diabetes mellitus and atherosclerosis. What is the optimal strategy for containing the atherosclerotic process? A Heart 2004; 1: 36-40.
Atroshchenko ES. A patient with chronic heart failure and preserved left ventricular systolic function. Journal of Heart Failure 2007; 8(6): 297-300.
Atroshchenko ES. Heart failure in patients with type 2 diabetes: problems and solutions. Journal of Heart Failure. 2008; 9(6): 300-303.
Atroshchenko ES, Kadochnikov NG, Solovey SP. Cardiovascular risk factors in women and men with type 2 diabetes who are hospitalized in a hospital. Journal of Women's Health Problems 2010; 5(1): 29-34.
Beytuganov AA, Rylova AK. The incidence of type 2 diabetes in patients with CHF. Journal of Heart Failure 2005; 5(6): 114-116.
Belenkov YuN, Mareev VYu. Principles of rational treatment of heart failure. M.: Media Medical 2000; p. 266.
Belenkov YuN, Mareev VYu. Cardiovascular continuum. Journal of Heart Failure 2002; ?(2): 7-11.
Borovikov VL. Popular introduction to the program STATISTICA. M.: Computer Press 2008; p. 267.
Gilyarovsky SR. Metabolic approaches to the treatment of CHF. Journal of Heart Failure 2008; 10(2): 11,51,22.
Glantz S. Biomedical statistics. M.: Practice, 2008; p. 459.
Gorokhova SG. Coenzyme Q10 in adjuvant treatment of cardiovascular diseases. Breast Cancer 2008; 16(11): 15581560.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2019 M.S. Kultayev, A.Zh. Yesirkepova, A.B. Abdugulova, A.B. Abdykulova , B.Zh. Kanseitova